Search

Your search keyword '"McErlane, Flora"' showing total 99 results

Search Constraints

Start Over You searched for: Author "McErlane, Flora" Remove constraint Author: "McErlane, Flora"
99 results on '"McErlane, Flora"'

Search Results

51. Patterns of pain over time among children with Juvenile Idiopathic Arthritis

52. Additional file 1: of Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trials

53. Development of a national audit tool for children and young people with juvenile idiopathic arthritis:a BSPAR project funded by the Health Care Quality Improvement Partnership

56. P07 Identifying the primary outcome measure and protocol components for a prospective feasibility study of corticosteroid regimens for CYP with JIA using consensus methods with young people, families and professionals

57. P05 A national survey of clinical practice of corticosteroid use in newly diagnosed or flaring cases of juvenile idiopathic arthritis across the UK

58. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis

59. AB0936 A NATIONAL SURVEY OF CLINICAL PRACTICE OF CORTICOSTEROID USE IN NEWLY DIAGNOSED OR FLARING CASES OF JUVENILE IDIOPATHIC ARTHRITIS ACROSS THE UK

60. FRI0541 HIGHLY ELEVATED FERRITIN LEVELS ARE ASSOCIATED WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS/MACROPHAGE ACTIVATION SYNDROME – ARE WE MISSING TREATABLE DIAGNOSES? A RETROSPECTIVE SERVICE EVALUATION OF DIAGNOSIS IN PATIENTS WITH FERRITIN >10,000 MICROGRAM/L

66. R06 Highly elevated ferritin levels are associated with haemophagocytic lymphohistiocytosis/macrophage activation syndrome: are we missing treatable diagnoses? A retrospective service evaluation of diagnosis in patients with ferritin >10,000 μg/L

68. Oral abstracts 3: RA Treatment and outcomesO13. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting

69. How Common is Clinically Inactive Disease in a Prospective Cohort of Patients with Juvenile Idiopathic Arthritis? The Importance of Definition

70. Effectiveness and Safety of TNF Inhibitors in Adults with Juvenile Idiopathic Arthritis

71. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.

72. Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis

74. 302 Highly elevated ferritin levels are associated with haemophagocytic lymphohistiocytosis/macrophage activation syndrome: are we missing treatable diagnoses? A retrospective service evaluation of diagnosis in patients with ferritin >10,000 microgram/L

76. O26 Describing current UK practice in assessment and management of juvenile localised scleroderma and consideration in context of PRES working party recommendations

77. Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective study

79. Patterns of pain over time among children with juvenile idiopathic arthritis

80. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership

82. How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition

87. Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.

89. List of Contributors

90. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children with juvenile idiopathic arthritis: results from the childhood arthritis prospective study

91. O49. Trends in Paediatric Rheumatology Referral Times and Disease Activity Indices Over a Ten-Year Period Among Children with Juvenile Idiopathic Arthritis: Results from the Childhood Arthritis Prospective Study

92. Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016

93. Oral abstracts 3: RA Treatment and outcomesO13. Validation of jadas in all subtypes of juvenile idiopathic arthritis in a clinical setting

94. Oral abstracts 3: RA Treatment and outcomes.

96. Wide variation in glucocorticoid dosing in paediatric ANCA-associated vasculitis with renal disease: a paediatric vasculitis initiative study.

97. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study.

98. Patterns of pain over time among children with juvenile idiopathic arthritis.

99. Cardiac disease causing death in a child with Wegener's granulomatosis.

Catalog

Books, media, physical & digital resources